Managing Body Distress in the Control of Severe Asthma

BakalD.; DavidsonW.

首页> 外文期刊>Journal of asthma & allergy educators. >Managing Body Distress in the Control of Severe Asthma

【24h】

Managing Body Distress in the Control of Severe Asthma

机译：在控制严重哮喘中控制身体不适

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

This article provides clinicians with a patient-centered framework for the recognition and management of body distress within severe asthma patients who remain uncontrolled despite treatment with standard medical therapy. Body distress is offered as a mind-body concept with origins in psychobiological patient characteristics that are generally not identified as contributing directly to uncontrolled asthma. Dysfunctional breathing can be viewed as a proxy for these patient variables. Effortless or relaxed breathing can be used to guide the reduction of body distress from healing sensations throughout the entire body and support a larger goal of using the least amount of medication possible.

机译：本文为临床医生提供了一个以患者为中心的框架，用于识别和管理严重哮喘患者的身体窘迫，这些哮喘患者尽管接受标准药物治疗仍无法控制。身体困扰是作为一种身心概念而提出的，其起源于心理生物学患者的特征，而这些特征通常没有被确定为直接导致不受控制的哮喘。呼吸功能障碍可以看作是这些患者变量的代表。不费吹灰之力或放松的呼吸可用于指导减轻整个身体的康复感觉所致的身体不适，并支持使用尽可能少的药物来实现更大的目标。

著录项

来源
《Journal of asthma & allergy educators.》 |2013年第1期|共6页
作者
BakalD.; DavidsonW.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类呼吸系及胸部疾病;
关键词
asthma education; asthma education issues; asthma management; comorbid conditions; depression; self-management;

机译：哮喘教育;哮喘教育问题;哮喘管理;合并症;抑郁症;自我管理;

相似文献

外文文献
中文文献
专利

1. Managing Body Distress in the Control of Severe Asthma [J] . BakalD., DavidsonW. Journal of asthma & allergy educators. . 2013,第1期

机译：在控制严重哮喘中控制身体不适
2. Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial [J] . Russell Richard J., Chachi Latifa, FitzGerald J. Mark, The lancet. Respiratory medicine. . 2018,第7期

机译：三丙酮，一种中腺素-13中和单克隆抗体，对非嗜酸性中和气道炎症的影响（MESOS）：多期，双盲，随机，安慰剂控制相2试验
3. Benralizumab, an anti-interleukin-5 receptor a monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial [J] . FitzGerald J. Mark, Bleecker Eugene R., Nair Parameswaran, The Lancet . 2016,第10056期

机译：Benralizumab，一种抗白细胞介素-5受体是单克隆抗体，作为严重，不受控制，嗜酸性嗜酸性哮喘（Calima）的患者的添加处理：随机，双盲，安慰剂控制第3阶段试验
4. Connections of Reduced Performance Health Data for Severe Persistent Uncontrolled Allergic Asthma Treated by Omazulimab [C] . Stefanos Matsopoulos, Valentina Plekhanova International Conference on Health Informatics . 2014

机译：omazulimab治疗严重持续不受控制的过敏性过敏性哮喘的性能健康数据减少的连接
5. The impact of severe housing stress on child asthma control and pediatric asthma caregiver quality of life (PACQOL). [D] . Kishore, Nina. 2014

机译：严重的住房压力对儿童哮喘控制和小儿哮喘护理人员的生活质量（PACQOL）的影响。
6. Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome [O] . Rosangela Villela, Janaina M Melo, Thais Nociti, 2015

机译：奥马珠单抗在难以控制的严重哮喘和抗磷脂抗体综合征患者中的疗效和安全性
7. A case of severe eosinophilic asthma and refractory rheumatoid arthritis well controlled by combination of IL-5Rα antibody and TNFα inhibitor [O] . Hideyasu Yamada, Norihito Hida, Yuko Kurashima, 2019

机译：通过IL-5Rα抗体和TNFα抑制剂的组合来控制严重的嗜酸性哮喘和难治性类气旋关节炎的情况

Managing Body Distress in the Control of Severe Asthma

摘要

著录项

相似文献

相关主题

期刊订阅